Outcome

A 23-year-old female with an 11-year history of treatment-resistant migraines experienced significant relief after undergoing 40 hyperbaric oxygen therapy sessions at 1.5 ATA over 8 weeks. She reported only one mild migraine with aura during the treatment period which was markedly less intense than previous episodes and did not cause debilitating pain.

Introduction

This study explores the promising application of hyperbaric oxygen therapy (HBOT) for treating migraines with aura in a 23-year-old woman. Suffering from severe treatment-resistant migraines for 11 years the patient underwent a total of 40 HBOT sessions administered at 1.5 absolute atmospheres (ATA) five days a week for eight weeks. During this period she reported a remarkable reduction in migraine intensity and frequency experiencing only a single mild migraine by her 24th treatment session. By the end of the treatment course the patient expressed high satisfaction having suffered only one mild episode throughout. This case suggests that HBOT has significant potential as a preventive treatment for migraines with aura highlighting the need for more comprehensive research in this area.

Results

The patient a 23-year-old female with an 11-year history of severe treatment-resistant migraines with aura underwent a total of 40 hyperbaric oxygen therapy (HBOT) sessions over an 8-week period receiving treatments at 1.5 absolute atmospheres (ATA). The sessions were conducted Monday through Friday for 1 hour each day with only a few sessions missed never more than one per week.

By her 24th treatment session the patient experienced a significant reduction in the frequency and intensity of her migraines. She reported only a single migraine with aura during this period which was notably less painful and debilitating than her previous migraines. The improvement was remarkable as she did not have to take any days off from work or school due to her condition.

At the conclusion of the 40-session treatment period the patient expressed high satisfaction with the results having experienced only the one mild migraine episode throughout the entire course of the therapy. This marked a significant departure from her previous experiences where her migraines were severe and led to a considerable loss of function.

The study highlights the potential efficacy of HBOT in providing relief for migraines with aura suggesting that further research is needed to explore HBOT as a preventive treatment for similar neurological conditions. The authors of the study declared no conflicts of interest and the funding sources were not specified.

Conclusion

In conclusion this case report highlights the promising potential of hyperbaric oxygen therapy (HBOT) for treating neurological conditions such as migraines with aura. A 23-year-old female who suffered from debilitating migraines for 11 years and found no relief with conventional drug therapies underwent 40 HBOT sessions over an 8-week period at 1.5 ATA. Remarkably by her 24th session she experienced only one mild migraine with aura a significant improvement compared to her previous severe episodes. By the end of the treatment period she had not endured any other migraines resulting in a highly satisfied patient with no days lost from work or school. Given these favorable results this study suggests that HBOT has the potential to serve as a prophylactic treatment for migraines with aura. However further research is needed to explore and confirm these findings. No conflicts of interest were reported and funding sources were not disclosed underlining the need for more extensive studies to validate the effectiveness of HBOT in treating resistant migraines.